• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    There is disclosed a process for the preparation of N7-amidino substituted mitomycin C derivatives. The process comprises reacting mitomycin C or an N1a substituted derivative thereof such as porfiromycin with a chloroformimidinium salt in a polar solvent at low temperature. This reaction is conducted in the presence of a tertiary amine. This process eliminates the need for a strong base such as NaH prior to addition of a chloroformimidinium salt.
    公开号:SU1436881A3
    申请号:SU864027308
    申请日:1986-04-28
    公开日:1988-11-07
    发明作者:Канеко Такучи；С.Л.Вонг Генри
    申请人:Бристоль-Мейерз Компани (Фирма)；
    IPC主号:
    专利说明:

    four
    with
    O5
    00
    00
     cm
    The invention relates to an improved method for the preparation of 7-amino-substituted 1 -9a-methoximntosan of the general formula:
    CHgOCONHj
    osnz
    n
    ten
    Rj
    RI and R where R is the lower alkyl group;
    lower alkyl or together with the nitrogen atom to which they are attached form pyrrolidine, piperidine or thiomorphol.
    The aim of the invention is to simplify the process by reducing the stages and expanding the range of target products with antitumor activity,
    Example 1, Preparation of 7- ((dimethylamino) -methylene -amino-9a-methoximitosane,
    To a solution of mitomycin C (3.7 mg, 1 mmol) in 5 ml of K, N-dimethylformamide (DMF) is added at -20 ° C with 4 ml of a 0.5 M solution of N, N-dimethylformamide chloride in CHClI, After 5 1 ml of triethylamine is added per minute. The reaction mixture is warmed to OH over a 20-minute period of time. The reaction mixture is diluted with and washed with water. Drying over and removing the solvents under reduced pressure gives a green residue. His chromatographic chromatography on an alumina column (2% - CH2Cl2) 8 to obtain 310 mg (80%) of the title compound.
    Example 2: Preparation of 7- (1-p-rrolidinylmethylene) -amino-9a-methoxy-mitosan.
    Substituting pyrrolidinyl formidium chloride with IC-formyl pyrrolidine instead of K, K-dimethyl formimidium chloride and DMF, respectively, in Example I, the above-named compound is obtained in 68% yield. The 5IMP data is identical with the literary data.
    Example 3. Polynuenum 7- (1 piperidinylmethylene) -amino-9a-methox mitosan.
    Substituted piperidinyl formamidium chloride and N-formylpiperidine instead of G1, N-dimethyl formidium chloride
    and DMF respectively in Example 1, the title compound was obtained in 64% yield. NMR data are identical with literature data.
    Example 4. Preparation of (di-isopropylamino) methylene -amino-9a-methoxymitosan.
    Substituting N, N-diisopropyl-imidinium chloride and N, K-diisopropyl-formamide instead of H, N-dimethyl-form-imidinium chloride and DMF, respectively, in Example I, the above-mentioned compound is obtained in 37% yield: NMR (pyridine-d5) ; 1.20 (m, 2H); 2.20 (singlet, SN); 2.76 (broad singlet, H); 3.18 (singlet, ZN); 3.23 (singlet, ZI); 3.54 (septet, 1H, Hz); 3.58 (lublet, W, I 14 Hz); 4.06 (double doublet, W, I 11.5 Hz); 4.48 (doublet, W, I 14 Hz); 4.74 (septet, 1H, Hz); 5.13 (triplet, 1H, I P Hz); 5.47 (double doublet, lli, I 11.5 Hz) 8.05 (singlet, 1H).
    Example 5. Preparation of 7- (thiomorpholin-1-yl-methylene) -amino-9a-to-x-tomo-titan.
    Substituting thiomorpholinyl formimidinium chloride and N-formylthiomorpholine instead of N, N-dimethyl formidinium chloride and DMF, respectively, in Example 1, the above-mentioned compound is obtained in 16% yield: NMR (pyridine-a5): 2.00 (singlet, NN ); 2.44 (multiplet, .4H); 2.60 (broad singlet, 1H); 3.00 (m, 1H); 3.09 (singlet, ZN); 3.44 (multiplet, 5H); 3.89 (double doublet, 1H, I 11.1 and 4.2 Hz) 4.26 (doublet, 1H), I 12.5 Hz) 4.80 (multiplet, 1H), 5.33 (double doublet, 1H, I 10.4 and 4.1 Hz) (singlet, 1H).
    Activity against cerebral leukemia P-388.
    The table presents the results of laboratory tests on CDF-type female females implanted intraperitoneally with soy tumor material from 10 P-388 mouse leukemia ascetic cells and treated with various doses of the test compound of Examples 4 and 5 and mitomycin C.
    Compounds were administered by intraperitoneal injection. Groups of six mice were used for each metered level and they were treated with a single dose of coupling 3,136,6881
    Dineni only once a day. Corpses, where R and R have the specified
    权利要求:
    Claims (1)
    [1]
    Claim
    A method of obtaining a 7-amino-substituted-9a-methoxymitosan of the general formula where R ( is lower alkyl;
    R 2 is lower alkyl or
    R, and R t, together with the nitrogen atom to which they are attached, form pyrrolidine, piperidine or thiomorpholine, based on mitomycin C, which requires that, in order to simplify the process and expand the range of target products, mitomycin C is subjected interaction with chloroformimidinium chloride of the general formula; n = chci Ci, i / where R 4 and R 2 have the indicated meanings.
    Soi Dose, t / s Average of dine mg / kg 7 ' change 15 nie livingsa, g / on weightsMOUSE
    Mitomi-
    Qing C 4.8 275 s, s 20 '-J 1 - 3.2 200 -1.61,6 169 0.40.8 144 0.3 25 0.4 138 0.8 Example4 6.4 131 -3.1 thirty3.2 175 -0.31,6 150 0.20.8 119 0.5 350.4 125 1,1 - ”- 0.2 106 0.3 40 ‘0.1 113 1,10.05 94 0.5 45 Example 5 6.4 100 -2.93.2 81 -3.2 JJI - 1,6 144 0.4 fifty0.8 163 0.2 - n - 0.4 119 -0.1 550.2 94 0.20.1 131 . 1.30.05 1 19 0.7
    类似技术:
    公开号 | 公开日 | 专利标题
    DE69533277T2|2005-07-21|DC-89 DERIVAT
    DE60315615T2|2008-10-02|TRICYCLIC COMPOUNDS BASED ON THIOPHES AND MEDICAMENTS COMPRISING THEM
    EP0660823B1|1996-08-14|N-cyano-n'-pyridylguanidines as serotonin antagonists
    KR20060009900A|2006-02-01|Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
    PL116437B1|1981-06-30|Process for preparing novel phthalazine derivatives
    EP0434057B1|1996-07-31|Indolocarbazole derivatives, processes for their preparation and their use
    KR20210136995A|2021-11-17|Bruton's Tyrosine Kinase Inhibitors
    CA1285934C|1991-07-09|Poly-4-aminopyrrole-2-carboxamido derivatives and process for their preparation
    US4271164A|1981-06-02|6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
    SU1436881A3|1988-11-07|Method of producing 7-aminosubstituted-9a-methoxymitozane
    EP0119428A2|1984-09-26|Biscarboxamides for treating diseases, and process for their preparation
    DE69817810T2|2004-07-01|CYANOGUANIDINE AS A CELL PROLIFERATION INHIBITOR
    EP0739892A2|1996-10-30|Chromone derivatives
    RU2162470C2|2001-01-27|2,7-substituted derivatives of octahydropyrrolo[1,2-a]pyrazine, method of treatment, pharmaceutical composition, and intermediates
    EP0520435A2|1992-12-30|DC-89 derivatives
    RU2195451C2|2002-12-27|Cyanoguanidines, methods of their synthesis and pharmaceutical preparation based on thereof
    EP0665228A1|1995-08-02|Pharmaceutical compositions containing 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes
    DE3531453C2|1996-07-18|Substituted 7-oxomitosan compound, pharmaceutical agent containing this compound, process for producing substituted 7-oxomitosan compounds
    WO1998043973A1|1998-10-08|Intermediate products and method for the production of pyrimidine derivatives
    CH665641A5|1988-05-31|ACYLAMINO MITOSANE.
    EP0565484A2|1993-10-13|HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides
    US5362738A|1994-11-08|Tricyclic pyridone derivatives
    EP0180833B1|1989-07-19|4-Oxo-pyrido-[2,3-d]pyrimidine derivatives, process for their preparation and medicaments containing them
    DD154487A5|1982-03-24|PROCESS FOR THE PREPARATION OF 1-BENZOXEPIN-5 | -ONE DERIVATIVES
    EP0055145B1|1984-12-05|4-|cyclohexane-1-carboxylic acid derivatives
    同族专利:
    公开号 | 公开日
    US4652644A|1987-03-24|
    CN1020731C|1993-05-19|
    IT8620228D0|1986-04-28|
    GR861152B|1986-09-02|
    PT82471B|1988-10-14|
    PT82471A|1986-05-01|
    DK193786D0|1986-04-28|
    KR910002080B1|1991-04-03|
    HU194243B|1988-01-28|
    DD258011A5|1988-07-06|
    YU45778B|1992-07-20|
    KR860008201A|1986-11-12|
    ATA101886A|1991-11-15|
    NO861652L|1986-10-30|
    CS311786A2|1989-12-13|
    CA1247617A|1988-12-28|
    DK193786A|1986-10-30|
    NO164543B|1990-07-09|
    AR242210A1|1993-03-31|
    HUT40665A|1987-01-28|
    IT1208605B|1989-07-10|
    FI861720A0|1986-04-24|
    YU70086A|1987-12-31|
    AT394724B|1992-06-10|
    DK168708B1|1994-05-24|
    ES8706685A1|1987-07-01|
    ZW5386A1|1986-10-01|
    LU86411A1|1986-11-05|
    CS271331B2|1990-09-12|
    FI861720A|1986-10-30|
    OA08243A|1987-10-30|
    CN86101611A|1986-12-17|
    ES554469A0|1987-07-01|
    FI83519B|1991-04-15|
    NO164543C|1990-10-17|
    FI83519C|1991-07-25|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    IT1135270B|1980-04-12|1986-08-20|Erba Farmitalia|3-amidino-ANSAMICINE|
    US4567256A|1983-05-09|1986-01-28|Bristol-Myers Company|Amidine process|
    US4487769A|1982-06-04|1984-12-11|Bristol-Myers Company|Amidines|JPS6354380A|1986-08-26|1988-03-08|Kyowa Hakko Kogyo Co Ltd|Mitomycin derivative|
    JPH0867676A|1994-03-30|1996-03-12|Eisai Kagaku Kk|Protected aminothiazolylacetic acid derivative|
    JP3202960B2|1998-02-17|2001-08-27|大塚化学株式会社|Halogenating agent and method for halogenating hydroxyl group|
    CN104710426B|2014-12-12|2017-08-01|常州大学|Western pyridine alkaloid and its production and use in benzopyrrole|
    CN104478885B|2014-12-12|2017-08-01|常州大学|The preparation method of 9 amino 9a pi-allyl benzo Pyrrolizidine alkaloids|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US06/728,650|US4652644A|1985-04-29|1985-04-29|Process for preparation of N7 -amidino substituted mitomycin C derivatives|
    [返回顶部]